These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18383837)

  • 1. Overexpression of the mitotic spindle assembly checkpoint genes hBUB1, hBUBR1 and hMAD2 in thyroid carcinomas with aggressive nature.
    Wada N; Yoshida A; Miyagi Y; Yamamoto T; Nakayama H; Suganuma N; Matsuzu K; Masudo K; Hirakawa S; Rino Y; Masuda M; Imada T
    Anticancer Res; 2008; 28(1A):139-44. PubMed ID: 18383837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival.
    Shichiri M; Yoshinaga K; Hisatomi H; Sugihara K; Hirata Y
    Cancer Res; 2002 Jan; 62(1):13-7. PubMed ID: 11782350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.
    Boltze C; Schneider-Stock R; Quednow C; Hinze R; Mawrin C; Hribaschek A; Roessner A; Hoang-Vu C
    Int J Mol Med; 2003 Oct; 12(4):479-84. PubMed ID: 12964023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer--association with tumour cell proliferation.
    Grabsch H; Takeno S; Parsons WJ; Pomjanski N; Boecking A; Gabbert HE; Mueller W
    J Pathol; 2003 May; 200(1):16-22. PubMed ID: 12692836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.
    Siraj AK; Bavi P; Abubaker J; Jehan Z; Sultana M; Al-Dayel F; Al-Nuaim A; Alzahrani A; Ahmed M; Al-Sanea O; Uddin S; Al-Kuraya KS
    J Pathol; 2007 Oct; 213(2):190-9. PubMed ID: 17703498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy.
    Tanaka K; Mohri Y; Ohi M; Yokoe T; Koike Y; Morimoto Y; Miki C; Tonouchi H; Kusunoki M
    Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):639-46. PubMed ID: 18691855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative measurement of telomerase reverse transcriptase, thyroglobulin and thyroid transcription factor 1 mRNAs in anaplastic thyroid carcinoma tissues and cell lines.
    Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A
    Oncol Rep; 2007 Sep; 18(3):715-20. PubMed ID: 17671725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability.
    Yuan B; Xu Y; Woo JH; Wang Y; Bae YK; Yoon DS; Wersto RP; Tully E; Wilsbach K; Gabrielson E
    Clin Cancer Res; 2006 Jan; 12(2):405-10. PubMed ID: 16428479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
    Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spindle checkpoint protein hMad2 and histone H3 phosphoserine 10 mitosis marker in pediatric solid tumors.
    Idikio HA
    Anticancer Res; 2006; 26(6C):4687-94. PubMed ID: 17214327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
    Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
    BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer.
    Chiappetta G; De Marco C; Quintiero A; Califano D; Gherardi S; Malanga D; Scrima M; Montero-Conde C; Cito L; Monaco M; Motti ML; Pasquinelli R; Agosti V; Robledo M; Fusco A; Viglietto G
    Endocr Relat Cancer; 2007 Jun; 14(2):405-20. PubMed ID: 17639054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weakened spindle checkpoint with reduced BubR1 expression in paclitaxel-resistant ovarian carcinoma cell line SKOV3-TR30.
    Fu Y; Ye D; Chen H; Lu W; Ye F; Xie X
    Gynecol Oncol; 2007 Apr; 105(1):66-73. PubMed ID: 17234259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.
    Melck A; Masoudi H; Griffith OL; Rajput A; Wilkins G; Bugis S; Jones SJ; Wiseman SM
    Ann Surg Oncol; 2007 Dec; 14(12):3403-11. PubMed ID: 17882495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different genotype distribution of the GNB3 C825T polymorphism of the G protein beta3 subunit in adenomas and differentiated thyroid carcinomas of follicular cell origin.
    Sheu SY; Görges R; Ensinger C; Ofner D; Farid NR; Siffert W; Schmid KW
    J Pathol; 2005 Dec; 207(4):430-5. PubMed ID: 16178055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent mutations of human Mad2, but not Bub1, in gastric cancers cause defective mitotic spindle checkpoint.
    Kim HS; Park KH; Kim SA; Wen J; Park SW; Park B; Gham CW; Hyung WJ; Noh SH; Kim HK; Song SY
    Mutat Res; 2005 Oct; 578(1-2):187-201. PubMed ID: 16112690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.
    Rivera M; Ghossein RA; Schoder H; Gomez D; Larson SM; Tuttle RM
    Cancer; 2008 Jul; 113(1):48-56. PubMed ID: 18484584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.
    Kehlen A; Lendeckel U; Dralle H; Langner J; Hoang-Vu C
    Cancer Res; 2003 Dec; 63(23):8500-6. PubMed ID: 14679016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.
    Ulivieri A; Lavra L; Dominici R; Giacomelli L; Brunetti E; Sciacca L; Trovato M; Barresi G; Foukakis T; Jia-Jing L; Larsson C; Bartolazzi A; Sciacchitano S
    J Pathol; 2008 May; 215(1):87-96. PubMed ID: 18306168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High periostin expression correlates with aggressiveness in papillary thyroid carcinomas.
    Puppin C; Fabbro D; Dima M; Di Loreto C; Puxeddu E; Filetti S; Russo D; Damante G
    J Endocrinol; 2008 May; 197(2):401-8. PubMed ID: 18434370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.